Genetic variation increases risk of metabolic side effects in children on some antipsychotics
25th January, 2012 - Posted by admin -
Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease. The study showed a close association with two conditions in particular: high blood pressure and elevated fasting blood sugar levels, which is a precursor to diabetes.
Posted on: January 25, 2012
Filed under: Asperger Syndome, Autism




No Comments
No Comments
Leave a reply